NCT00223821View on ClinicalTrials.gov

Enhancing Conservative Treatment for Urge Incontinence

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2009

Conditions
Urinary Incontinence
Interventions
DRUG

Oxybutynin chloride, extended-release, individually-titrated

Individually-titrated, extended-release oxybutynin chloride with management of side-effects.

BEHAVIORAL

Behavior Training

Behavioral training consists of teaching urge suppression strategies and pelvic floor muscle training.

Trial Locations (1)

35233

Birmingham VA Medical Center, Birmingham

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00223821 - Enhancing Conservative Treatment for Urge Incontinence | Biotech Hunter | Biotech Hunter